BridgeBio Pharma, Inc. (BBIO)
66.13
-3.53
(-5.07%)
USD |
NASDAQ |
May 15, 16:00
66.12
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Profit Margin (Quarterly) : -85.63% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | -494.2% |
| Pfizer Inc. | 18.75% |
| Insmed, Inc. | -53.46% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Vanda Pharmaceuticals, Inc. | -93.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -69.29% |
| Return on Invested Capital | -87.57% |
| Gross Profit Margin (Quarterly) | 94.64% |
| Operating Margin (Quarterly) | -54.47% |
| Return on Net Operating Assets | -374.1% |